Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The pharmacokinetic basis of insulin therapy in diabetes mellitus.

Literature DB >> 2666060

The pharmacokinetic basis of insulin therapy in diabetes mellitus.

G B Bolli¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Insulin

Year: 1989 PMID： 2666060 DOI： 10.1016/0168-8227(89)90073-9

Source DB: PubMed Journal: Diabetes Res Clin Pract ISSN： 0168-8227 Impact factor: 5.602

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp.

Authors: S V M Hordern; J E Wright; A M Umpleby; F Shojaee-Moradie; J Amiss; D L Russell-Jones
Journal: Diabetologia Date: 2005-02-24 Impact factor: 10.122

2. The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

Authors: G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal: Diabetologia Date: 1991-01 Impact factor: 10.122

3. Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia.

Authors: S Pampanelli; C Fanelli; C Lalli; M Ciofetta; P D Sindaco; M Lepore; F Modarelli; A M Rambotti; L Epifano; A Di Vincenzo; L Bartocci; B Annibale; P Brunetti; G B Bolli
Journal: Diabetologia Date: 1996-06 Impact factor: 10.122

4. Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique.

Authors: H E Scholtz; S G Pretorius; D H Wessels; R H A Becker
Journal: Diabetologia Date: 2005-09-14 Impact factor: 10.122

5. Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM.

Authors: E Torlone; C Fanelli; A M Rambotti; G Kassi; F Modarelli; A Di Vincenzo; L Epifano; M Ciofetta; S Pampanelli; P Brunetti
Journal: Diabetologia Date: 1994-07 Impact factor: 10.122

The pharmacokinetic basis of insulin therapy in diabetes mellitus.

1. Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp.

2. The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

3. Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia.

4. Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique.

5. Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM.

6. Serum insulin profiles in consecutive children 2 years after the diagnosis of IDDM.

7. Modeling Pharmacokinetic Profiles of Insulin Regimens to Enhance Understanding of Subcutaneous Insulin Regimens.

Review 8. The Evolution of Insulin and How it Informs Therapy and Treatment Choices.